Biogen Inc. stock underperforms Thursday when compared to competitors
Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.
Zacks Investment Research on MSN13h
IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi
Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...
RFK Jr. reportedly plans 10,000 job cuts in HHS with FDA, CDC, Medicare affected
The U.S. Health Department plans to cut 10,000 jobs, impacting agencies such as the FDA, CDC, NIH, and Medicare. Read more ...
The Harvard Crimson20h
Biogen to Move Global Headquarters to Kendall Commons in 2028
Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...